
Why Most AI Pilots Fail in Regulated Environments and How to Fix It
Discover why AI pilots in pharma often fail before production and how governance, workflows, and data foundations determine success.
Read moreExpert guidance across pharma, biotech, and medical devices — stay ahead of industry trends and best practices.

Discover why AI pilots in pharma often fail before production and how governance, workflows, and data foundations determine success.
Read more
Discover how MedTech's validated AI approach can help pharma accelerate compliant AI adoption across R&D, clinical trials, and GMP operations.
Read more
Discover why governance, validation, and trust, not model performance, are the real challenges for AI adoption in life sciences.
Read more
Discover why AI governance in life sciences depends on intended use, risk context, and control frameworks rather than the AI label itself.
Read more
Developing Software as a Medical Device under EU MDR requires clear intended use, risk classification under Rule 11, and compliance with IEC 62304. Learn what SaMD developers need to know.
Read more
Learn why QMS validation matters in pharma, what regulators expect, and how to apply Annex 11, 21 CFR Part 11, and GAMP 5 best practices to stay compliant.
Read more
Learn what the new EudraLex Annex 22 means for AI regulation in pharma and how it could impact your daily operations and compliance efforts.
Read more
Cybersecurity is a key MDR requirement. Discover what your technical file must include to meet EU cybersecurity expectations for medical devices.
Read more
The EU is revising Annex 11 to align GMP with digital realities. Discover what’s changing and how to prepare for compliance before 2026.
Read more
Validating your LIMS is essential for compliance, data integrity, and audit readiness. Discover key steps, common pitfalls, and best practices for success.
Read more
AI providers and deployers must ensure AI literacy as of Feb 2025. Learn what it means, who's responsible, and how to turn compliance into opportunity.
Read more
Pharma 4.0 is redefining the pharmaceutical industry with AI, IoT, and Big Data. Discover the benefits, challenges, and how QbD can support your transition.
Read more
Conduct risk-based periodic reviews of GxP systems: log changes, verify docs/security, close CAPAs, and confirm Annex 11 validation stays intact.
Read moreWe use cookies to enhance your experience
We use essential cookies for site functionality and optional analytics cookies to improve our services. Read our Privacy Policy and Cookie Policy.